MOLT-4 Acute Lymphocytic Leukemia Cells (MOLT-4)

The MOLT-4 cell line is a human T lymphoblastoid leukemia cell line that was originally derived from the peripheral blood of a 29-year-old male patient with leukemia. The MOLT-4 cells are widely used in cancer research, particularly in studies related to T cell leukemia and lymphoma.

These cells are characterized by their rapid proliferation, high growth rate, and ability to be maintained in culture for extended periods of time. The MOLT-4 cell line is commonly used as a model system to study the biology of T cell leukemia and lymphoma, as well as to investigate the mechanisms underlying malignant transformation, cell proliferation, differentiation, and drug resistance in these diseases.

The MOLT-4 cell line is a valuable tool for researchers studying T cell leukemia and lymphoma, and its use has contributed significantly to our understanding of the pathogenesis and treatment of these diseases. Ongoing research using the MOLT-4 cell line may lead to the development of new therapeutic approaches and improved outcomes for patients with T cell malignancies in the future.